Click for best price
Immunotherapy Market Size, Share 2024
This report aims to provide a comprehensive presentation of the global market for Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunotherapy. This report contains market size and forecasts of Immunotherapy in global, including the following market information:
Global Immunotherapy Market Revenue, 2019-2024, 2024-2029, ($ millions)
Global top five companies in 2023 (%)
The global Immunotherapy market was valued at US$ million in 2023 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Monoclonal Antibodies Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Immunotherapy include Abbvie, Amgen, Inc., Biogen, Bristol-Myers Squibb, Celgene, Johnson & Johnson, Merck, Novartis and Pfizer, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Immunotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immunotherapy Market, by Type, 2019-2024, 2024-2029 ($ millions)
Global Immunotherapy Market Segment Percentages, by Type, 2023 (%)
Monoclonal Antibodies
Therapeutic Vaccines
Checkpoint Inhibitors
Non-Specific Immunotherapy
Global Immunotherapy Market, by Application, 2019-2024, 2024-2029 ($ millions)
Global Immunotherapy Market Segment Percentages, by Application, 2023 (%)
Oncology
Inflammation
Central Nervous System
Others
Global Immunotherapy Market, By Region and Country, 2019-2024, 2024-2029 ($ Millions)
Global Immunotherapy Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immunotherapy revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Immunotherapy revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbvie
Amgen, Inc.
Biogen
Bristol-Myers Squibb
Celgene
Johnson & Johnson
Merck
Novartis
Pfizer
Roche
Outline of Major Chapters:
Chapter 1: Introduces the definition of Immunotherapy, market overview.
Chapter 2: Global Immunotherapy market size in revenue.
Chapter 3: Detailed analysis of Immunotherapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Immunotherapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Immunotherapy Market, Global Outlook and Forecast 2024-2031 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Immunotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immunotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immunotherapy Overall Market Size
2.1 Global Immunotherapy Market Size: 2022 VS 2031
2.2 Global Immunotherapy Market Size, Prospects & Forecasts: 2019-2031
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Immunotherapy Players in Global Market
3.2 Top Global Immunotherapy Companies Ranked by Revenue
3.3 Global Immunotherapy Revenue by Companies
3.4 Top 3 and Top 5 Immunotherapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Immunotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immunotherapy Players in Global Market
3.6.1 List of Global Tier 1 Immunotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Immunotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Immunotherapy Market Size Markets, 2022 & 2031
4.1.2 Monoclonal Antibodies
4.1.3 Therapeutic Vaccines
4.1.4 Checkpoint Inhibitors
4.1.5 Non-Specific Immunotherapy
4.2 By Type - Global Immunotherapy Revenue & Forecasts
4.2.1 By Type - Global Immunotherapy Revenue, 2019-2024
4.2.2 By Type - Global Immunotherapy Revenue, 2024-2031
4.2.3 By Type - Global Immunotherapy Revenue Market Share, 2019-2031
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Immunotherapy Market Size, 2022 & 2031
5.1.2 Oncology
5.1.3 Inflammation
5.1.4 Central Nervous System
5.1.5 Others
5.2 By Application - Global Immunotherapy Revenue & Forecasts
5.2.1 By Application - Global Immunotherapy Revenue, 2019-2024
5.2.2 By Application - Global Immunotherapy Revenue, 2024-2031
5.2.3 By Application - Global Immunotherapy Revenue Market Share, 2019-2031
6 Sights by Region
6.1 By Region - Global Immunotherapy Market Size, 2022 & 2031
6.2 By Region - Global Immunotherapy Revenue & Forecasts
6.2.1 By Region - Global Immunotherapy Revenue, 2019-2024
6.2.2 By Region - Global Immunotherapy Revenue, 2024-2031
6.2.3 By Region - Global Immunotherapy Revenue Market Share, 2019-2031
6.3 North America
6.3.1 By Country - North America Immunotherapy Revenue, 2019-2031
6.3.2 US Immunotherapy Market Size, 2019-2031
6.3.3 Canada Immunotherapy Market Size, 2019-2031
6.3.4 Mexico Immunotherapy Market Size, 2019-2031
6.4 Europe
6.4.1 By Country - Europe Immunotherapy Revenue, 2019-2031
6.4.2 Germany Immunotherapy Market Size, 2019-2031
6.4.3 France Immunotherapy Market Size, 2019-2031
6.4.4 U.K. Immunotherapy Market Size, 2019-2031
6.4.5 Italy Immunotherapy Market Size, 2019-2031
6.4.6 Russia Immunotherapy Market Size, 2019-2031
6.4.7 Nordic Countries Immunotherapy Market Size, 2019-2031
6.4.8 Benelux Immunotherapy Market Size, 2019-2031
6.5 Asia
6.5.1 By Region - Asia Immunotherapy Revenue, 2019-2031
6.5.2 China Immunotherapy Market Size, 2019-2031
6.5.3 Japan Immunotherapy Market Size, 2019-2031
6.5.4 South Korea Immunotherapy Market Size, 2019-2031
6.5.5 Southeast Asia Immunotherapy Market Size, 2019-2031
6.5.6 India Immunotherapy Market Size, 2019-2031
6.6 South America
6.6.1 By Country - South America Immunotherapy Revenue, 2019-2031
6.6.2 Brazil Immunotherapy Market Size, 2019-2031
6.6.3 Argentina Immunotherapy Market Size, 2019-2031
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Immunotherapy Revenue, 2019-2031
6.7.2 Turkey Immunotherapy Market Size, 2019-2031
6.7.3 Israel Immunotherapy Market Size, 2019-2031
6.7.4 Saudi Arabia Immunotherapy Market Size, 2019-2031
6.7.5 UAE Immunotherapy Market Size, 2019-2031
7 Immunotherapy Companies Profiles
7.1 Abbvie
7.1.1 Abbvie Company Summary
7.1.2 Abbvie Business Overview
7.1.3 Abbvie Immunotherapy Major Product Offerings
7.1.4 Abbvie Immunotherapy Revenue in Global Market (2019-2024)
7.1.5 Abbvie Key News & Latest Developments
7.2 Amgen, Inc.
7.2.1 Amgen, Inc. Company Summary
7.2.2 Amgen, Inc. Business Overview
7.2.3 Amgen, Inc. Immunotherapy Major Product Offerings
7.2.4 Amgen, Inc. Immunotherapy Revenue in Global Market (2019-2024)
7.2.5 Amgen, Inc. Key News & Latest Developments
7.3 Biogen
7.3.1 Biogen Company Summary
7.3.2 Biogen Business Overview
7.3.3 Biogen Immunotherapy Major Product Offerings
7.3.4 Biogen Immunotherapy Revenue in Global Market (2019-2024)
7.3.5 Biogen Key News & Latest Developments
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Immunotherapy Major Product Offerings
7.4.4 Bristol-Myers Squibb Immunotherapy Revenue in Global Market (2019-2024)
7.4.5 Bristol-Myers Squibb Key News & Latest Developments
7.5 Celgene
7.5.1 Celgene Company Summary
7.5.2 Celgene Business Overview
7.5.3 Celgene Immunotherapy Major Product Offerings
7.5.4 Celgene Immunotherapy Revenue in Global Market (2019-2024)
7.5.5 Celgene Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Immunotherapy Major Product Offerings
7.6.4 Johnson & Johnson Immunotherapy Revenue in Global Market (2019-2024)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 Merck
7.7.1 Merck Company Summary
7.7.2 Merck Business Overview
7.7.3 Merck Immunotherapy Major Product Offerings
7.7.4 Merck Immunotherapy Revenue in Global Market (2019-2024)
7.7.5 Merck Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Immunotherapy Major Product Offerings
7.8.4 Novartis Immunotherapy Revenue in Global Market (2019-2024)
7.8.5 Novartis Key News & Latest Developments
7.9 Pfizer
7.9.1 Pfizer Company Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Immunotherapy Major Product Offerings
7.9.4 Pfizer Immunotherapy Revenue in Global Market (2019-2024)
7.9.5 Pfizer Key News & Latest Developments
7.10 Roche
7.10.1 Roche Company Summary
7.10.2 Roche Business Overview
7.10.3 Roche Immunotherapy Major Product Offerings
7.10.4 Roche Immunotherapy Revenue in Global Market (2019-2024)
7.10.5 Roche Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Immunotherapy Market Opportunities & Trends in Global Market
Table 2. Immunotherapy Market Drivers in Global Market
Table 3. Immunotherapy Market Restraints in Global Market
Table 4. Key Players of Immunotherapy in Global Market
Table 5. Top Immunotherapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Immunotherapy Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Immunotherapy Revenue Share by Companies, 2019-2024
Table 8. Global Companies Immunotherapy Product Type
Table 9. List of Global Tier 1 Immunotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immunotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Immunotherapy Revenue, (US$, Mn), 2022 & 2031
Table 12. By Type - Immunotherapy Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Immunotherapy Revenue in Global (US$, Mn), 2024-2031
Table 14. By Application ? Global Immunotherapy Revenue, (US$, Mn), 2022 & 2031
Table 15. By Application - Immunotherapy Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Immunotherapy Revenue in Global (US$, Mn), 2024-2031
Table 17. By Region ? Global Immunotherapy Revenue, (US$, Mn), 2022 & 2031
Table 18. By Region - Global Immunotherapy Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Immunotherapy Revenue (US$, Mn), 2024-2031
Table 20. By Country - North America Immunotherapy Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Immunotherapy Revenue, (US$, Mn), 2024-2031
Table 22. By Country - Europe Immunotherapy Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Immunotherapy Revenue, (US$, Mn), 2024-2031
Table 24. By Region - Asia Immunotherapy Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Immunotherapy Revenue, (US$, Mn), 2024-2031
Table 26. By Country - South America Immunotherapy Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Immunotherapy Revenue, (US$, Mn), 2024-2031
Table 28. By Country - Middle East & Africa Immunotherapy Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Immunotherapy Revenue, (US$, Mn), 2024-2031
Table 30. Abbvie Company Summary
Table 31. Abbvie Immunotherapy Product Offerings
Table 32. Abbvie Immunotherapy Revenue (US$, Mn) & (2019-2024)
Table 33. Abbvie Key News & Latest Developments
Table 34. Amgen, Inc. Company Summary
Table 35. Amgen, Inc. Immunotherapy Product Offerings
Table 36. Amgen, Inc. Immunotherapy Revenue (US$, Mn) & (2019-2024)
Table 37. Amgen, Inc. Key News & Latest Developments
Table 38. Biogen Company Summary
Table 39. Biogen Immunotherapy Product Offerings
Table 40. Biogen Immunotherapy Revenue (US$, Mn) & (2019-2024)
Table 41. Biogen Key News & Latest Developments
Table 42. Bristol-Myers Squibb Company Summary
Table 43. Bristol-Myers Squibb Immunotherapy Product Offerings
Table 44. Bristol-Myers Squibb Immunotherapy Revenue (US$, Mn) & (2019-2024)
Table 45. Bristol-Myers Squibb Key News & Latest Developments
Table 46. Celgene Company Summary
Table 47. Celgene Immunotherapy Product Offerings
Table 48. Celgene Immunotherapy Revenue (US$, Mn) & (2019-2024)
Table 49. Celgene Key News & Latest Developments
Table 50. Johnson & Johnson Company Summary
Table 51. Johnson & Johnson Immunotherapy Product Offerings
Table 52. Johnson & Johnson Immunotherapy Revenue (US$, Mn) & (2019-2024)
Table 53. Johnson & Johnson Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Immunotherapy Product Offerings
Table 56. Merck Immunotherapy Revenue (US$, Mn) & (2019-2024)
Table 57. Merck Key News & Latest Developments
Table 58. Novartis Company Summary
Table 59. Novartis Immunotherapy Product Offerings
Table 60. Novartis Immunotherapy Revenue (US$, Mn) & (2019-2024)
Table 61. Novartis Key News & Latest Developments
Table 62. Pfizer Company Summary
Table 63. Pfizer Immunotherapy Product Offerings
Table 64. Pfizer Immunotherapy Revenue (US$, Mn) & (2019-2024)
Table 65. Pfizer Key News & Latest Developments
Table 66. Roche Company Summary
Table 67. Roche Immunotherapy Product Offerings
Table 68. Roche Immunotherapy Revenue (US$, Mn) & (2019-2024)
Table 69. Roche Key News & Latest Developments
List of Figures
Figure 1. Immunotherapy Segment by Type in 2022
Figure 2. Immunotherapy Segment by Application in 2022
Figure 3. Global Immunotherapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Immunotherapy Market Size: 2022 VS 2031 (US$, Mn)
Figure 6. Global Immunotherapy Revenue, 2019-2031 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Immunotherapy Revenue in 2022
Figure 8. By Type - Global Immunotherapy Revenue Market Share, 2019-2031
Figure 9. By Application - Global Immunotherapy Revenue Market Share, 2019-2031
Figure 10. By Type - Global Immunotherapy Revenue, (US$, Mn), 2022 & 2031
Figure 11. By Type - Global Immunotherapy Revenue Market Share, 2019-2031
Figure 12. By Application - Global Immunotherapy Revenue, (US$, Mn), 2022 & 2031
Figure 13. By Application - Global Immunotherapy Revenue Market Share, 2019-2031
Figure 14. By Region - Global Immunotherapy Revenue Market Share, 2019-2031
Figure 15. By Country - North America Immunotherapy Revenue Market Share, 2019-2031
Figure 16. US Immunotherapy Revenue, (US$, Mn), 2019-2031
Figure 17. Canada Immunotherapy Revenue, (US$, Mn), 2019-2031
Figure 18. Mexico Immunotherapy Revenue, (US$, Mn), 2019-2031
Figure 19. By Country - Europe Immunotherapy Revenue Market Share, 2019-2031
Figure 20. Germany Immunotherapy Revenue, (US$, Mn), 2019-2031
Figure 21. France Immunotherapy Revenue, (US$, Mn), 2019-2031
Figure 22. U.K. Immunotherapy Revenue, (US$, Mn), 2019-2031
Figure 23. Italy Immunotherapy Revenue, (US$, Mn), 2019-2031
Figure 24. Russia Immunotherapy Revenue, (US$, Mn), 2019-2031
Figure 25. Nordic Countries Immunotherapy Revenue, (US$, Mn), 2019-2031
Figure 26. Benelux Immunotherapy Revenue, (US$, Mn), 2019-2031
Figure 27. By Region - Asia Immunotherapy Revenue Market Share, 2019-2031
Figure 28. China Immunotherapy Revenue, (US$, Mn), 2019-2031
Figure 29. Japan Immunotherapy Revenue, (US$, Mn), 2019-2031
Figure 30. South Korea Immunotherapy Revenue, (US$, Mn), 2019-2031
Figure 31. Southeast Asia Immunotherapy Revenue, (US$, Mn), 2019-2031
Figure 32. India Immunotherapy Revenue, (US$, Mn), 2019-2031
Figure 33. By Country - South America Immunotherapy Revenue Market Share, 2019-2031
Figure 34. Brazil Immunotherapy Revenue, (US$, Mn), 2019-2031
Figure 35. Argentina Immunotherapy Revenue, (US$, Mn), 2019-2031
Figure 36. By Country - Middle East & Africa Immunotherapy Revenue Market Share, 2019-2031
Figure 37. Turkey Immunotherapy Revenue, (US$, Mn), 2019-2031
Figure 38. Israel Immunotherapy Revenue, (US$, Mn), 2019-2031
Figure 39. Saudi Arabia Immunotherapy Revenue, (US$, Mn), 2019-2031
Figure 40. UAE Immunotherapy Revenue, (US$, Mn), 2019-2031
Figure 41. Abbvie Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Amgen, Inc. Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Biogen Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Bristol-Myers Squibb Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Celgene Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Johnson & Johnson Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Merck Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Novartis Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Pfizer Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Roche Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
